HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial.

AuthorsGeorge D Kalliolias, Panagiotis E Georgiou, Ioannis A Antonopoulos, Andrew P Andonopoulos, Stamatis-Nick C Liossis
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 66 Issue 6 Pg. 842-3 (Jun 2007) ISSN: 0003-4967 [Print] England
PMID17513574 (Publication Type: Clinical Trial, Letter)
Chemical References
  • Antirheumatic Agents
  • Glucocorticoids
  • Interleukin 1 Receptor Antagonist Protein
Topics
  • Adolescent
  • Adult
  • Antirheumatic Agents (therapeutic use)
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Glucocorticoids (administration & dosage)
  • Humans
  • Interleukin 1 Receptor Antagonist Protein (therapeutic use)
  • Male
  • Middle Aged
  • Still's Disease, Adult-Onset (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: